Follow-up of sickle cell disease patients with priapism treated by hydroxyurea

American Journal of Hematology

Volumn 77, Issue 1, 2004, Pages 45-49

  Saad, Sara T O ^a   Lajolo, Camila ^a   Gilli, Simone ^a   Marques Jr , José Francisco C ^a   Lima, Carmen S ^a   Costa, Fernando F ^a   Arruda, Valder R ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Hydroxyurea; Priapism; Sickle cell

Indexed keywords

HYDROXYUREA;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ARTICLE; AZOOSPERMIA; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; IMPOTENCE; MALE; OLIGOSPERMIA; PAIN; PRIAPISM; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RETREATMENT; SEXUAL BEHAVIOR; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; MALE; PRIAPISM; SEXUAL BEHAVIOR; TREATMENT OUTCOME;

EID: 4243162037     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20142     Document Type: Article

References (39)

1. Serjeant GR. Screening for sickle cell disease in Brazil. Lancet 2000;356:168-169.
2. Hebbel RP. Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle cell erythrocytes with endothelium. J Clin Invest 1997;99:2561-2564.
3. Fadlon E, Vordermeier S, Pearson TC, et al. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood 1998;91:266-274.
4. Steinberg MH, Rodgers GP. Pathophysiology of sickle cell disease: role of cellular and genetic modifiers. Semin Hematol 2001;38:299-306.
5. Powars DR, Johnson CS. Priapism. Hematol Oncol Clin North Am 1996;10:1363-1372.
6. rd edition. New York: Oxford University Press; 2001.
7. Edmond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980;140:1434-1437.
8. rd. Urological complications of sickle cell disease in a pediatric population. J Urol 1987;138:592-594.
9. Fowler JE Jr, Koshy M, Strub M, Chinn SK. Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 1991;145:65-68.
10. Adeyoju AB, Olujohungbe ABK, Morris J, et al. Priapism in sickle-cell disease; incidence, risk factors and complications-an international multicentre study. BJU Int 2002;90:898-902.
11. Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 1999;21:518-522.
12. Bruno D, Wigfall DR, Zimmerman SA, Rosoff PM, Wiener JS. Genitourinary complications of sickle cell disease. J Urol 2001;166:803-811.
13. Hamre MR, Harmon EP, Kirkpatrick DV, Stern MJ, Humbert JR. Priapism as a complication of sickle cell disease. J Urol 1991;145:1-5.
14. Serjeant GR, De Ceulaer K, Maude GH. Stilboestrol and stuttering priapism in homozygous sickle cell disease. Lancet 1985; ii:1274-1276.
15. Campbell LC, Von Burton G, Holcombe RF. Transfusion therapy in sickle cell disease patients. J State Med Soc 1993;145:515-521.
16. rd. Urologic manifestations of hematologic disease sickle cell, leukemia, and thromboembolic disease. Urol Clin North Am 2003;30:49-61.
17. Colombani JF, Peluchon P, Elana G, Delatre P. Priapism in a sickle cell prepuberal child. Eur J Pediatr Surg 2000;10:68-71.
18. Chakrabarty A, Upadhyay J, Dhabuwala CB, Sarnaik S, Perlmutter AD, Connor JP. Priapism associated with sickle cell hemoglobinopathy in children: long-term effects on potency. J Urol 1996;155:1419-1423.
19. Maples BL, Hagemann TM. Treatment of priapism in pediatric patients with sickle cell disease. Am J Health Syst Pharm 2004;61:355-363.
20. Steinberg J, Eyre RC. Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue. J Urol 1995;153:152-153.
21. Virag R, Bachir D, Lee K, Galacteros F. Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology 1996;47:777-781.
22. Mantadakis E, Ewalt DH, Cavender JD, Rogers ZR, Buchanan GR. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 2000;95:78-82.
23. Gbadoé AD, Atakouma Y, Kusiaku K, Assimadi JK. Management of sickle cell priapism with etilefrine. Arch Dis Child 2001;85:52-53.
24. Dahm P, Rao DS, Donatucci CF Antiandrogens in the treatment of priapism. Urology 2002;59:138.
25. Okpala I, Westerdale N, Jegede T, Cheung B. Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Haematol 2002;118:918-921.
26. McCarthy LJ, Vattuone J, Weidner J, et al. Do automated red cell exchanges relieve priapism in patients with sickle cell anemia? Ther Apher 2000;4:256-258.
27. Danielson CF. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002;6:24-31.
28. Rackoff WR, Ohene-Frempong K, Month S, Scott JP, Neahring B, Cohen AR. Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr 1992;120:882-885.
29. Siegel JF, Rich MA, Brock WA. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome. J Urol 1993;150(5 Pt 1):1480-1482.
30. Miller ST, Rao SP, Dunn EK, Glassberg KI. Priapism in children with sickle cell disease. J Urol 1995;154(2 Pt 2):844-847.
31. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-1322.
32. Steinberg MH, Lu Z-H, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood 1997;89:1078-1088.
33. Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Blood 1999;94:1550-1554.
34. Styles LA, Lubin B, Vichinsky E, et al. Decrease of very late antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 1997;89:2554-2559.
35. Gladwin MT, Schechter AN. Nitric oxide therapy in sickle cell disease. Semin Hematol 2001;38:333-342.
36. Al Jam'a AH, Al Dabbous IA. Hydroxyurea in the treatment of sickle cell associated priapism. J Urol 1998;159:1642.
37. Lima CSP, Arruda VR, Costa FF, Saad STO. Minimal doses of hydroxyurea for sickle cell disease. Braz J Med Biol Res 1997;30:933-940.
38. Bialecki ES, Bridges KR. Sildenafil relieves priapism in patients with sickle cell disease. Am J Med 2002;113:252.
39. Diggs LW, Ching RE. Pathology of sickle cell anemia. Southern Med J 1934;27:839-845.